Poland
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 251.14 M
|
Dec. 31, 2023 | USD 204.85 | 1.34% |
|
Poland |
|
2 |
USD 218.62 M
|
Dec. 31, 2023 | USD 12.79 | 0.55% |
|
Poland |
|
3 |
USD 153.77 M
|
Dec. 31, 2023 | USD 0.77 | 0.43% |
|
Poland |
|
4 |
USD 112.99 M
|
Dec. 31, 2023 | USD 6.09 | -0.44% |
|
Poland |
|
5 |
USD 82.94 M
|
Dec. 31, 2023 | USD 11.11 | -3.75% |
|
Poland |
|
6 |
USD 65.83 M
|
Dec. 31, 2023 | USD 7.78 | -9.75% |
|
Poland |
|
7 |
USD 49.89 M
|
Sept. 30, 2024 | USD 50.91 | 0.74% |
|
Poland |
|
8 |
USD 40.66 M
|
Dec. 31, 2023 | USD 4.92 | 2.76% |
|
Poland |
|
9 |
USD 29.87 M
|
Dec. 31, 2023 | USD 2.34 | 1.69% |
|
Poland |
|
10 |
USD 28.56 M
|
Dec. 31, 2023 | USD 1.05 | -1.52% |
|
Poland |
|
11 |
USD 22.19 M
|
Dec. 31, 2023 | USD 9.29 | -3.28% |
|
Poland |
|
12 |
USD 20.52 M
|
Dec. 31, 2023 | USD 40.10 | -0.57% |
|
Poland |
|
13 |
USD 17.55 M
|
Dec. 31, 2023 | USD 10.54 | 0.97% |
|
Poland |
|
14 |
USD 11.91 M
|
Dec. 31, 2023 | USD 2.77 | 1.63% |
|
Poland |
|
15 |
USD 8.41 M
|
Dec. 31, 2023 | USD 1.85 | -0.17% |
|
Poland |
|
16 |
USD 6.75 M
|
Dec. 31, 2023 | USD 0.71 | 0.06% |
|
Poland |
|
17 |
USD 5.71 M
|
Dec. 31, 2023 | USD 1.01 | 1.23% |
|
Poland |
|
18 |
USD 2.65 M
|
Dec. 31, 2023 | USD 20.34 | -1.25% |
|
Poland |
|
19 |
USD 2.11 M
|
Dec. 31, 2023 | USD 1.74 | 1.31% |
|
Poland |
The Pharmaceuticals company in Poland with the highest Shareholders' Equity is NEUCA S.A. (Warsaw Stock Exchange: NEU.WA) at USD 251.14 M.
The Pharmaceuticals company in Poland with the lowest Shareholders' Equity is Genomtec S.A. (Warsaw Stock Exchange: GMT.WA) at USD 2.11 M.
The top 10 Pharmaceuticals companies in Poland by Shareholders' Equity are NEUCA S.A., Mercator Medical S.A., BIOTON S.A., Celon Pharma S.A., Selvita S.A., Ryvu Therapeutics S.A., Synektik Spólka Akcyjna, Centrum Medyczne ENEL-MED S.A., Mabion S.A. and Synthaverse S.A..
The bottom 10 Pharmaceuticals companies in Poland by Shareholders' Equity are Genomtec S.A., Bioceltix S.A., Pharmena S.A., M.W. Trade SA, Medinice S.A., BioMaxima S.A., Captor Therapeutics Spolka Akcyjna, Scope Fluidics S.A., Poltreg S.A. and Synthaverse S.A..